SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,167,727 | +50.1% | 42,355 | +63.7% | 0.11% | +57.1% |
| Q2 2023 | $777,923 | -15.2% | 25,879 | +2.2% | 0.07% | -21.3% |
| Q1 2023 | $917,162 | +2.5% | 25,315 | +0.9% | 0.09% | 0.0% |
| Q4 2022 | $894,925 | +8.9% | 25,089 | +3.3% | 0.09% | -4.3% |
| Q3 2022 | $822,000 | +19.8% | 24,298 | +2.5% | 0.09% | +27.4% |
| Q2 2022 | $686,000 | -6.5% | 23,715 | +4.5% | 0.07% | +2.8% |
| Q1 2022 | $734,000 | +13.1% | 22,696 | +2.0% | 0.07% | +22.4% |
| Q4 2021 | $649,000 | +12.3% | 22,253 | +2.7% | 0.06% | -1.7% |
| Q3 2021 | $578,000 | -9.0% | 21,669 | +5.0% | 0.06% | -4.8% |
| Q2 2021 | $635,000 | +24.3% | 20,639 | +5.8% | 0.06% | +14.8% |
| Q1 2021 | $511,000 | +9.2% | 19,512 | +4.9% | 0.05% | +1.9% |
| Q4 2020 | $468,000 | +30.4% | 18,600 | +8.0% | 0.05% | +15.2% |
| Q3 2020 | $359,000 | -10.7% | 17,219 | +1.8% | 0.05% | -16.4% |
| Q2 2020 | $402,000 | +33.1% | 16,912 | +0.9% | 0.06% | +5.8% |
| Q1 2020 | $302,000 | -27.4% | 16,764 | -4.5% | 0.05% | -7.1% |
| Q4 2019 | $416,000 | -13.9% | 17,559 | -0.1% | 0.06% | -18.8% |
| Q3 2019 | $483,000 | -17.6% | 17,584 | -0.8% | 0.07% | -19.8% |
| Q2 2019 | $586,000 | +0.9% | 17,721 | +7.0% | 0.09% | -4.4% |
| Q1 2019 | $581,000 | +8.2% | 16,567 | +2.5% | 0.09% | -3.2% |
| Q4 2018 | $537,000 | -26.4% | 16,170 | +11.5% | 0.09% | -11.4% |
| Q3 2018 | $730,000 | -11.3% | 14,501 | +5.5% | 0.10% | -17.3% |
| Q2 2018 | $823,000 | +36.9% | 13,751 | +4.8% | 0.13% | +27.0% |
| Q1 2018 | $601,000 | +20.2% | 13,118 | +4.5% | 0.10% | +19.0% |
| Q4 2017 | $500,000 | +22.0% | 12,551 | +22.4% | 0.08% | +15.1% |
| Q3 2017 | $410,000 | +6.5% | 10,250 | +14.7% | 0.07% | +5.8% |
| Q2 2017 | $385,000 | +44.2% | 8,938 | +4.8% | 0.07% | +40.8% |
| Q1 2017 | $267,000 | – | 8,525 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |